Publications by authors named "Dimos D Mitsikostas"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

52,619

Total Likes

2,406

Extended Reach

1,280,749

Social Features

518
M
Migraine stigma and general knowledge of migraine: A cross-sectional European survey.
Peter J Goadsby, Elena Ruiz de la Torre, Antoinette Maassen van den Brink, Pablo Irimia, Dimos D Mitsikostas, Messoud Ashina, Gisela M Terwindt, David Hurtado, Christian Lampl, Patricia Pozo-Rosich

Cephalalgia· September 2025

Videos about Article: user

1 1 2 7

View All Article and Social Media Activity
D
Diagnosis and management of migraine in ten steps.
Anna K Eigenbrodt, Håkan Ashina, Sabrina Khan, Hans-Christoph Diener, Dimos D Mitsikostas, Alexandra J Sinclair, Patricia Pozo-Rosich, Paolo Martelletti, Anne Ducros, Michel Lantéri-Minet

Nat Rev Neurol· August 2021

Videos about Article: user user

2 8 290 9

View All Article and Social Media Activity
T
Tension-type headache.
Sait Ashina, Dimos D Mitsikostas, Mi Ji Lee, Nooshin Yamani, Shuu-Jiun Wang, Roberta Messina, Håkan Ashina, Dawn C Buse, Patricia Pozo-Rosich, Rigmor H Jensen

Nat Rev Dis Primers· March 2021

Videos about Article: user user

2 15 6 200 2

View All Article and Social Media Activity
L
Long-term real-world effectiveness and safety of fremanezumab in 1140 patients with migraine and at least 6 months of treatment: third interim analysis of the pan-European PEARL study.
Messoud Ashina, Dimos D Mitsikostas, Faisal Mohammad Amin, Pinar Kokturk, Christoph J Schankin

Neurol Sci· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Steps to manage treatment-refractory migraine in adults.
Dimos D Mitsikostas, Christina Deligianni, Artemis Mavridi, Victor Gkotzamanis, Theodoros Mavridis

Expert Rev Neurother· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Number Needed to Treat and Cost Per Responder Analysis of Anti-CGRP Monoclonal Antibodies for Migraine Prevention in Adults for Whom Prior Preventive Treatments have Failed.
Dimos D Mitsikostas, Susanne F Awad, Rikke Kongerslev, Line Pickering Boserup, Xin Ying Lee

Adv Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hallmarks of primary headache: part 3 - cluster headache.
Gianluca Coppola, Marco Antônio Arruda, Messoud Ashina, Mads Barloese, Andrea Carmine Belin, Dimos D Mitsikostas

J Headache Pain· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of GLP-1 and Dual GIP/GLP-1 Receptor Agonists in Idiopathic Intracranial Hypertension: A Systematic Review and Meta-Analysis.
Maria-Ioanna Stefanou, Irini Chatziralli, Vaia Lambadiari, Annerose Mengel, Aikaterini Foska, Dimos D Mitsikostas

Eur J Neurol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Longitudinal assessment of migraine burden in resistant and refractory migraine - Data from the prospective REFINE study.
Umberto Pensato, Raffaele Ornello, Chiara Rosignoli, Valeria Caponnetto, Agnese Onofri, Dimos D Mitsikostas

J Headache Pain· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Migraine and Tension-Type Headache Are Associated with Multiple Sclerosis: A Case-Control Study.
Panagiotis Gklinos, Maria-Eleftheria Evangelopoulos, Georgios Velonakis, Dimos Dimitrios Mitsikostas

J Clin Med· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Continuing evolution of migraine-specific therapies - targeting migraine with precision and persistence.
Dimos D Mitsikostas, Alan Rapoport

Nat Rev Neurol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The evolving landscape of neuromodulation for pain care.
Jean-Pascal Lefaucheur, Yinghui Fan, Bifa Fan, Perianen Ramasawmy, Andrea Antal, Dimos D Mitsikostas

Cell Rep Med· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Onabotulinumtoxina in the Prevention of Migraine in Pediatric Population: A Systematic Review.
Artemis Mavridi, Aine Redmond, Paraschos Archontakis-Barakakis, Petya Bogdanova-Mihaylova, Christina I Deligianni, Dimos D Mitsikostas

Toxins (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Placebo responses vary by route of administration in migraine prevention trials. What does this mean?
Christina I Deligianni, Paolo Martelletti, Dimos D Mitsikostas

J Med Econ· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Depression and Anxiety Symptoms in Headache Disorders: An Observational, Cross-Sectional Study.
Leonidas Mantonakis, Ioanna Belesioti, Christina I Deligianni, Vasilis Natsis, Euthimia Mitropoulou, Dimos D Mitsikostas

Neurol Int· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial.
Messoud Ashina, Richard B Lipton, Jessica Ailani, Jan Versijpt, Simona Sacco, Dimos D Mitsikostas

Eur J Neurol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evidence-based symptomatic treatment of migraine.
Dimos D Mitsikostas, Thomas N Ward

Handb Clin Neurol· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nocebo-associated treatment discontinuation with subcutaneous anti-osteoporotic drugs. A systematic review and meta-analysis of placebo-arm dropouts in randomized-controlled trials.
Maria P Yavropoulou, Maria-Iosifina Kasdagli, Polyzois Makras, Konstantina-Maria Diomatari, Athanasios D Anastasilakis, Dimos D Mitsikostas

Maturitas· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The World Health Organization Intersectoral Global Action Plan on Epilepsy and Other Neurological Disorders and the headache revolution: from headache burden to a global action plan for headache disorders.
Matilde Leonardi, Paolo Martelletti, Rami Burstein, Arianna Fornari, Licia Grazzi, Dimos Dimitrios Mitsikostas

J Headache Pain· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications: A post hoc analysis.
Messoud Ashina, Dimos D Mitsikostas, Verena Ramirez Campos, Steve Barash, Xiaoping Ning

Headache· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world effectiveness of fremanezumab for the preventive treatment of migraine: Interim analysis of the pan-European, prospective, observational, phase 4 PEARL study.
Messoud Ashina, Dimos D Mitsikostas, Faisal Mohammad Amin, Pinar Kokturk, Christoph J Schankin

Cephalalgia· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030.
Paolo Martelletti, Matilde Leonardi, Messoud Ashina, Rami Burstein, Soo-Jin Cho, Dimos Dimitrios Mitsikostas

J Headache Pain· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The 5-HT receptor as the target of ditans in migraine - from bench to bedside.
Dimos D Mitsikostas, Christian Waeber, Margarita Sanchez-Del-Rio, Bianca Raffaelli, Håkan Ashina

Nat Rev Neurol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Headache Attributed to Reversible Cerebral Vasoconstriction Syndrome (RCVS).
Vasileios Tentolouris-Piperas, Loukas Lymperopoulos, Argyro Tountopoulou, Sophia Vassilopoulou, Dimos D Mitsikostas

Diagnostics (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are indirect comparisons for treatments in migraine necessitas? Many inevitable challenges to overcome.
Christina Deligianni, Paolo Martelletti, Dimos D Mitsikostas

J Comp Eff Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rimegepant for migraine: acute efficacy beyond the USA.
Dimos D Mitsikostas

Lancet Neurol· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence and burden of medication overuse headache in Greece.
Theodoros S Constantinidis, Chryssa Arvaniti, Nikolaos Fakas, Jobst Rudolf, Evangelos Kouremenos, Dimos D Mitsikostas

Cephalalgia· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis